LEAP 2 Chronic EFS
NCT: NCT07287423 · RECRUITING
NCT IDNCT07287423
StatusRECRUITING
Start Date2025-12-13
Completion2028-12
SponsorAbbott Medical Devices (INDUSTRY)
First posted
Last updated
Brief Summary
Prospective, single-arm, non-randomized, unblinded, chronic feasibility study designed to evaluate the safety and performance of the AVEIR™ Conduction System Pacing (CSP) Leadless Pacemaker system.
Frequently Asked Questions
What is LEAP 2 Chronic EFS?
LEAP 2 Chronic EFS is a clinical trial registered under NCT07287423. Current status: RECRUITING.
What is the status of NCT07287423?
The current status of NCT07287423 (LEAP 2 Chronic EFS) is: RECRUITING.
When did LEAP 2 Chronic EFS start?
LEAP 2 Chronic EFS started on 2025-12-13.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.